Background.
Disinfection of contaminated or potentially contaminated surfaces has become an integral part of the mitigation strategies for controlling coronavirus disease 2019. Whilst a broad range of disinfectants are effective in inactivating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), application of disinfectants has a low throughput in areas that receive treatments. Disinfection of large surface areas often involves the use of reactive microbiocidal materials, including ultraviolet germicidal irradiation, chlorine dioxide, and hydrogen peroxide vapor. Albeit these methods are highly effective in inactivating SARS-CoV-2, the deployment of these approaches creates unacceptable health hazards and precludes the treatment of occupied indoor spaces using existing disinfection technologies. Deployment of dry hydrogen peroxide (DHP) is an emerging pathogen reduction technology, which produces hydrogen peroxide in the ambient atmosphere at 5 and 25 parts per billion using a commercially available catalytic unit. The low concentration of hydrogen peroxide released using DHP technology has been found to be tolerated by humans in indoor spaces and is effective in inactivating bacterial pathogens responsible for nosocomial infections. In this study, the feasibility of using DHP in inactivating SARS-CoV-2 on contaminated surfaces in large indoor spaces was evaluated.
Methods.
Glass slides were inoculated with SARS-CoV-2 and treated with DHP for up to 24 hours. Residual infectious virus samples were eluted and titrated in African green monkey VeroE6 cells.
Results.
In comparison with the observed relatively high stability of SARS-CoV-2 on contaminated glass slides in the control group, residual infectious titers of glass slides inoculated with SARS-CoV-2 were significantly reduced after receiving 120 minutes of DHP treatment.
Conclusions.
The accelerated decay of SARS-CoV-2 on contaminated glass slides suggests that treatment with DHP can be an effective surface disinfection method for occupied indoor spaces.